Catheter Precision (VTAK) Net Shares Issued and Repurchased (2017 - 2026)

Catheter Precision (VTAK) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $200000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased fell 87.71% year-over-year to $200000.0 in Q1 2026; TTM through Mar 2026 was $200000.0, a 87.71% decrease from a year earlier, with the FY2024 full-year figure at $66000.0, down 52.07% from the prior year.
• Net Shares Issued and Repurchased was $200000.0 for Q1 2026 at Catheter Precision, down from $1.6 million in the prior quarter.
• Over five years, Net Shares Issued and Repurchased peaked at $1.6 million in Q1 2025 and troughed at $35.0 in Q1 2023.
• A 5-year average of $259399.4 and a median of $50529.5 in 2024 frame the typical range for Net Shares Issued and Repurchased.
• Across the five-year window, Net Shares Issued and Repurchased plunged 99.55% in 2023 and surged 100068.57% in 2024, its largest moves.
• Over 5 years, Net Shares Issued and Repurchased stood at $1104.0 in 2022, then soared by 12373.64% to $137709.0 in 2023, then plunged by 52.07% to $66000.0 in 2024, then jumped by 2365.91% to $1.6 million in 2025, then plunged by 87.71% to $200000.0 in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $200000.0 (Q1 2026), $1.6 million (Q1 2025), and $66000.0 (Q4 2024), per Business Quant data.